The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rasagiline Bluefish 1 mg tablets

Bluefish Pharmaceuticals ABPA1436/028/001

Main Information

Trade NameRasagiline Bluefish 1 mg tablets
Active SubstancesRasagiline
Dosage FormTablet
Licence HolderBluefish Pharmaceuticals AB
Licence NumberPA1436/028/001

Group Information

ATC CodeN04BD02 rasagiline


License statusAuthorised
Licence Issued14/02/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListRasagiline 1mg Tablets
Interchangeable List CodeIC0112-039-002
Interchangeable List DocumentPDF of Interchangeable List
« Back